30Mar 2017

LOW SERUM VITAMIN D LEVELS IN EGYPTIAN ADULTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A SINGLE CENTER STUDY.

  • Clinical Hematology and Bone Marrow Transplant Unit, Internal medicine department , Faculty of Medicine ? Ain Shams University, Cairo, Egypt.
  • Faculty of medicine- MisurataUniveristy, Misurata, Libya.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objectives: Immune thrombocytopenia (ITP) is a disorder characterized by immune-mediated accelerated platelet destruction and suppressed platelet production. Low vitamin D levels have been found in several autoimmune diseases, such as rheumatoid arthritis, SLE. The mechanisms underlying the link between vitamin D with autoimmunity are not completely understood. No currently available studies about vitamin D status in primary ITP patients. Aim: To evaluate vitamin D levels in patients with primary chronic ITP and compare these levels with normal control subjects and patients with thrombocytopenia due to other non-immune causes Methods: The study included 80 adult subjects, 40 ITP patients (They were segregated into 20 responders and 20 non-responders), 20 cases of thrombocytopenia due to non ITP causes and 20 healthy control subjects. Measurement of serum 25monohydroxyvitamin D was done with ELISA. Results: Vitamin D levels were significantly lower in patients with ITP (range=2-40ng/ml; mean?SD=17.29?10.96 ng/ml) and thrombocytopenia due to non-ITP causes (range=10-40ng/ml; mean?SD=21.05?8.31 ng/ml) in comparison to normal healthy controls (range = 10-65 ng/ml; mean?SD=36.70?16.30 ng/ml) (P=0.000), but there was no statistically significant difference between levels in ITP versus non- ITP thrombocytopenia (P=0.225).There was no statistical significant difference between responders & non-responders Conclusions: Vitamin D levels are lower among chronic ITP patients in relation to healthy control subjects which might point out to a role in aetiopathogenesis of ITP attributable to vitamin D deficiency.

  1. Neunert C, Lim W, Crowther M, et al. (2011): American Society of Hematology evidence-based practice guidelines for immune thrombocytopenia. Blood; 117: 4190-207.
  2. Stasi R (2012): Immune Thrombocytopenia: Pathophysiologic and Clinical Update. SeminThrombHemost; 38: 454-62.
  3. DeLuca HF (2004): Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr; 80:1689S?96S.
  4. Schwalfenberg G K. (2012): Solar Radiation and Vitamin D: Mitigating Environmental Factors in Autoimmune Disease. Journal of Environmental and Public Health; 2012: 1-9.
  5. Agmon-Levin N, Theodor E, Segal RM, et al. (2013): Vitamin D in Systemic and Organ-Specific Autoimmune Diseases. Clinic Rev AllergImmunol; 45: 256-66.
  6. Antico A, Tozzoli R, Giavarina D, et al. (2012):Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case?control study and review of the literature on the interaction vitamin D with the immune system. Clin Rev Allergy Immunol;42:355?64.
  7. Provan D, Stasi R, Newland AC, et al. (2010): International consensus report on the investigation and management of primary immune thrombocytopenic. Blood; 115:168?86.
  8. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. (2011): Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J ClinEndocrinolMetab.; 96: 1911-30.
  9. McMillan R(2007): The pathogenesis of chronic immune thrombocytopenic purpura. SeminHematol.; 44:S3-11.
  10. Gatenby P, Lucas R and Swaminathan A (2013): Vitamin D deficiency and risk forrheumatic diseases: an update. ;25: 184?91.
  11. Schoonen?WM,?Kucera?G,?Coalson?J,?et al. (2009): Epidemiology of immune thrombocytopenic purpura in the general practice research database.?Br J Haematol; 145: 235-44.
  12. Saeidi S, Jaseb K, Asnafi A, et al. (2014): Immune Thrombocytopenic Purpura in Children and Adults: A Comparative Retrospective Study in IRAN.?International Journal of Hematology-Oncology and Stem Cell Research; 8: 30-36.
  13. Cines DB and Bussel JB (2005): How I treat thrombocytopenic purpura (ITP). Blood; 106: 2244-51.
  14. Neylon N, Saunders G, Howard R, et al. (2003): Clinically significant newly diagnosed presenting autoimmune thrombocytopenic pupura in adults: a prospective study of a population-based cohort of 245 patients. British Journal of Haematology; 122: 966?74.
  15. Ntaios G, Papadopoulos A, Chatzinikolaou A, et al. (2008): Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura. ActaHaematologica.; 119: 173?77.
  16. Negash M, Tsegaye A and MedhinA(2016): Diagnostic predictive value of platelet indices for discriminating hypo productive versus immune thrombocytopenia purpura. BMC Hematology; 16: 1-8.
  17. Borkataky S, Jain R and Gupta R (2013): Role of platelet volume indices in the differential diagnosis of thrombocytopenia: a simple and inexpensive method. Hematoloy; 14: 182-86.
  18. Colkesen Y and?Muderrisoglu H (2012): The role of mean platelet volume in predicting thrombotic events.ClinChem Lab Med.; 50: 631-34.
  19. Elsammak MY, Al-Wossaibi AA, Al-Howeish A, et al. (2011): High prevalence of vitamin D deficiency in the sunny Eastern region of Saudi Arabia: a hospital-based study.?East Mediterr Health J.; 17: 317?22.
  20. Amital H,?Szekanecz Z,?Sz?cs G, et al. (2010): Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis.; 69: 1155-57.
  21. Wright TB, Shults J, Leonard MB, et al. (2009): Hypovitaminosis D is Associated with Greater Body Mass Index and Disease Activity in Pediatric Systemic Lupus Erythematosus.JPediatr.; 52: 1333-40.
  22. Emam FE, Abd El-Wahab TM, Mohammed MS, et al. (2014): Assessment of serum vitamin D level in patients with systemic lupus erythematosus. Egyptian Rheumatology and Rehabilitation; 41: 71-78.
  23. Rossini M, Bongi MS,?LaMontagna G, et al. (2010):Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res. Ther; 12: R216.
  24. Dias de Castro F, Magalh?es J, BoalCarvalho P, et al. (2015): Lower levels of vitamin D correlate with clinical disease activity and quality of life in inflammatory bowel disease.ArqGastroenterol; 52: 260-65.
  25. Karatay S, Yildirim K, Karakuzu A, et al. (2011): Vitamin D status in patients with Behcet?s Disease. CLINICS; 66: 721-23.
  26. Damanhouri LH (2009): Vitamin D Deficiency in Saudi Patients with Systemic Lupus Erythematosus. Saudi Med J.; 30: 1291- 95.
  27. Fragoso TS, Dantas AT, Marques CD et al. (2012): 25-Hydroxyivitamin D3 levels in patients with systemic lupus erythematosus and its association with clinical parameters and laboratory tests. Rev Bras Reumatol; 52: 60-65.
  28. Fattizzo B, Zaninoni A, Giannotta JA, et al. (2016): Reduced 25-OH vitamin D in patients with autoimmune cytopenias,clinical correlations and literature review. Autoimmunity Reviews; 15: 770-75.
  29. Mu W, Wang W, Cui ZG, et al. (2013): Expression and significance of vitamin D and its receptor mRNA in the peripheral blood of initial immune thrombocytopenic patients. Journal of experimental hematology;21:684?87.
  30. Haga HJ, Schmedes A, Naderi Y, et al. (2013): Severe deficiency of 25-hydroxyvitamin D3 is associated with high disease activity of rheumatoid arthritis. ClinRheumatol.; 32: 629-33.
  31. Ricceri F, Pescitelli L, Tripo L, et al. (2013): Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis. J Am AcadDermatol; 68: 511?12.
  32. Mok CC, Birmingham DJ, Leung HW, et al. (2012): Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.Rheumatology; 51: 644?52.
  33. Ruiz-Irastorza G, Gordo S, Olivares N, et al.(2010): Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken); 62: 1160?65.
  34. D'Aurizio F, Villalta D, Metus P, et al. (2015): Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev; 14: 363?69.
  35. Levin AD, Wadhera V, Leach ST, et al. (2011):Vitamin D deficiency in children with inflammatory bowel disease Dig Dis Sci.; 56: 830-36.
  36. Holick MF.(2007): Vitamin D deficiency. New Engl J Med; 357:266?81.
  37. SchoindreY,Jallouli M, Tanguy ML et al. (2014): Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive ofdisease flare-up. LupusScience& Medicine.; 1: e000027.
  38. Toloza S, Cole D and Gladman D (2010): Vitamin D insufficiency in a large female SLE cohort. Lupus.; 19: 13-19.
  39. Bockow B and Kaplan TB, (2013): Refractory immune thrombocytopenia successfully treated with high-dose vitamin D supplementation and hydroxychloroquine: two case Journal of Medical Case Reports; 7: 91.

[Abdel Rahman A Soliman, M.D, Walaa A Elsalakawy M.D, Alia M Saeed M.D and Sana A Mohammed M.B., B. CH. (2017); LOW SERUM VITAMIN D LEVELS IN EGYPTIAN ADULTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A SINGLE CENTER STUDY. Int. J. of Adv. Res. 5 (Mar). 1789-1797] (ISSN 2320-5407). www.journalijar.com

Walaa Ali Elsalakawy
MD

DOI:

Article DOI: 10.21474/IJAR01/3692      
DOI URL: https://dx.doi.org/10.21474/IJAR01/3692

Download Full Paper

Download PDF No. of Downloads: 51 | No. of Views: 240